Riskpilot← Back to searchSign inGet full accessAPOTEK 1 BJORBEKK AS
ASActiveOrg 921675933Rykeneveien 109, 4824 BjorbekkRetail sale of pharmaceutical products · NACE 4773Est. 20189 employees
Revenue 2024
NOK 47,2M
+13% vs 2023
EBITDA margin
5.9%
+8% vs 2023
Equity ratio
10.2%
Financial strength
Net profit 2024
NOK 2,1M
+11% vs 2023
| Revenue | NOK 47,2M | +13% |
| EBITDA | NOK 2,8M | +8% |
| Net profit | NOK 2,1M | +11% |
| Total assets | NOK 9,8M | -32% |
| Equity | NOK 1M | +0% |
| Employees | 9 | — |
Legal name
APOTEK 1 BJORBEKK AS
Org number
921675933
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
6. november 2018
Share capital
NOK 1 000 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder og ett styremedlem i fellesskap.
Company purpose
Eie og drift av apotek.
Address
Rykeneveien 109, 4824 Bjorbekk
Phone
+4737405666
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 25 670 | 29 794 | 34 011 | 41 709 | 47 225 |
| Staff expenses | −2 956 | −3 711 | −3 744 | −4 384 | −4 949 |
| EBITDA | 1 534 | 1 287 | 1 796 | 2 577 | 2 796 |
| Depreciation & amort. | −158 | −179 | −179 | −179 | −171 |
| EBIT | 1 376 | 1 109 | 1 618 | 2 399 | 2 625 |
| Net financials | −2 | −2 | −2 | 52 | 99 |
| Profit before tax | 1 374 | 1 107 | 1 616 | 2 450 | 2 724 |
| Tax | 302 | 243 | 356 | 539 | 600 |
| Net profit | 1 072 | 863 | 1 260 | 1 911 | 2 124 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 954 | 6 810 | 7 350 | 14 324 | 9 788 |
| Equity | 1 220 | 1 083 | 1 143 | 1 000 | 1 000 |
| Long-term debt | 27 | 29 | 22 | 17 | 12 |
| Short-term debt | 4 707 | 5 698 | 6 185 | 13 308 | 8 775 |
| Total debt | 4 734 | 5 727 | 6 207 | 13 324 | 8 788 |
EBITDA margin
5.9%
This company
15.8%
Market median
-63% vs market
20202024
Equity ratio
10.2%
This company
38.2%
Market median
-73% vs market
20202024
Return on equity
212.4%
This company
18.4%
Market median
+1054% vs market
20202024
Net profit margin
4.5%
This company
8.1%
Market median
-44% vs market
20202024
Asset turnover
4.83×
This company
1.12×
Market median
+331% vs market
20202024
Debt / equity
8.79×
This company
0.62×
Market median
-1318% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RM Chief Executive Officer | Chief Executive Officer | 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2018 | |
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Madsen & Thygesen Holding As
APOTEK 1 BJORBEKK AS Board members of APOTEK 1 BJORBEKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ragnar Madsen | Chief Executive Officer | 0 companies |
| Lloyd Thygesen | Chairman | 0 companies |
| Børge Moholt | Chairman | 0 companies |
| Øystein Askim | Board of Directors | 0 companies |